http://142-54-23-223.fusionmedialtd.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 16 Jul 2026 17:09:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://142-54-23-223.fusionmedialtd.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jul+14++Filed+by%3A+Coastlands+Capital+LP/26780518.html si-local-file:///var/storage/secattach/20260716/26780518.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jul+14++Filed+by%3A+Coastlands+Capital+LP/26780518.html Thu, 16 Jul 2026 17:09:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jul+14++Filed+by%3A+Coastlands+Capital+LP/26780518.html si-local-file:///var/storage/secattach/20260716/26780518.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jul+14++Filed+by%3A+Coastlands+Capital+LP/26780518.html Thu, 16 Jul 2026 17:09:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jul+09++Filed+by%3A+Coastlands+Capital+LP/26761106.html si-local-file:///var/storage/secattach/20260713/26761106.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jul+09++Filed+by%3A+Coastlands+Capital+LP/26761106.html Mon, 13 Jul 2026 10:30:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jul+09++Filed+by%3A+Coastlands+Capital+LP/26761106.html si-local-file:///var/storage/secattach/20260713/26761106.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jul+09++Filed+by%3A+Coastlands+Capital+LP/26761106.html Mon, 13 Jul 2026 10:30:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ADIAL+PHARMACEUTICALS%2C+++++++++++++++++Filed+by%3A+Coastlands+Capital+LP/26722650.html si-local-file:///var/storage/secattach/20260701/26722650.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ADIAL+PHARMACEUTICALS%2C+++++++++++++++++Filed+by%3A+Coastlands+Capital+LP/26722650.html Wed, 01 Jul 2026 20:02:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ADIAL+PHARMACEUTICALS%2C+++++++++++++++++Filed+by%3A+Coastlands+Capital+LP/26722650.html si-local-file:///var/storage/secattach/20260701/26722650.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++ADIAL+PHARMACEUTICALS%2C+++++++++++++++++Filed+by%3A+Coastlands+Capital+LP/26722650.html Wed, 01 Jul 2026 20:02:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+29++Filed+by%3A+Coastlands+Capital+LP/26718441.html si-local-file:///var/storage/secattach/20260701/26718441.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+29++Filed+by%3A+Coastlands+Capital+LP/26718441.html Wed, 01 Jul 2026 10:30:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+29++Filed+by%3A+Coastlands+Capital+LP/26718441.html si-local-file:///var/storage/secattach/20260701/26718441.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+29++Filed+by%3A+Coastlands+Capital+LP/26718441.html Wed, 01 Jul 2026 10:30:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+24++Filed+by%3A+Coastlands+Capital+LP/26704762.html si-local-file:///var/storage/secattach/20260629/26704762.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+24++Filed+by%3A+Coastlands+Capital+LP/26704762.html Mon, 29 Jun 2026 12:47:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+24++Filed+by%3A+Coastlands+Capital+LP/26704762.html si-local-file:///var/storage/secattach/20260629/26704762.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+24++Filed+by%3A+Coastlands+Capital+LP/26704762.html Mon, 29 Jun 2026 12:47:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++ADIAL+PHARMACEUTICALS%2C+++++++++++++++++Filed+by%3A+Coastlands+Capital+LP/26683771.html si-local-file:///var/storage/secattach/20260624/26683771.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++ADIAL+PHARMACEUTICALS%2C+++++++++++++++++Filed+by%3A+Coastlands+Capital+LP/26683771.html Wed, 24 Jun 2026 10:30:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++ADIAL+PHARMACEUTICALS%2C+++++++++++++++++Filed+by%3A+Coastlands+Capital+LP/26683771.html si-local-file:///var/storage/secattach/20260624/26683771.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++ADIAL+PHARMACEUTICALS%2C+++++++++++++++++Filed+by%3A+Coastlands+Capital+LP/26683771.html Wed, 24 Jun 2026 10:30:00 -0400 ADIL O.37097991 http://www.streetinsider.com/Corporate+News/Adial+Pharmaceuticals+closes+%2432M+PIPE+tranche+and+grants+stock+awards+to+new+hires/26650754.html <p>Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) closed the first $32 million tranche of a previously announced up to $64 million private placement on June 12, 2026, according to a company statement. The financing included the conversion of outstanding notes assumed in the company's acquisition of Azora Therapeutics, Inc.</p><p>The private placement was led by Coastlands Capital, with participation from Kern Capital, Boxer Capital Management, Stonepine Capital Management, AuGC BioFund, and other institutional investors.</p><p>Jay Kern, Founder and General Partner of Kern Capital, said, "Kern Capital focuses on differentiated life sciences programs with outstanding management teams and the potential to become market leaders within http://www.streetinsider.com/Corporate+News/Adial+Pharmaceuticals+closes+%2432M+PIPE+tranche+and+grants+stock+awards+to+new+hires/26650754.html Tue, 16 Jun 2026 08:01:53 -0400 ADIL http://www.streetinsider.com/Press+Releases/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html <p align="justify">GLEN ALLEN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company’s newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company common stock as an inducement to them becoming employees of the Company in connection with the closing of its business combination with Azora Therapeutics, Inc. (“Azora”), which was previously announced by the Company on June 11, 2026. Additionally, the http://www.streetinsider.com/Press+Releases/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html Tue, 16 Jun 2026 08:00:00 -0400 A.50216902 ADIL O.37097991 O.45953338 http://www.streetinsider.com/Press+Releases/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html <p align="justify">GLEN ALLEN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company’s newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company common stock as an inducement to them becoming employees of the Company in connection with the closing of its business combination with Azora Therapeutics, Inc. (“Azora”), which was previously announced by the Company on June 11, 2026. Additionally, the http://www.streetinsider.com/Press+Releases/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html Tue, 16 Jun 2026 08:00:00 -0400 A.50216902 ADIL O.37097991 O.45953338 http://www.streetinsider.com/Press+Releases/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html <p align="justify">GLEN ALLEN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company’s newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company common stock as an inducement to them becoming employees of the Company in connection with the closing of its business combination with Azora Therapeutics, Inc. (“Azora”), which was previously announced by the Company on June 11, 2026. Additionally, the http://www.streetinsider.com/Press+Releases/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html Tue, 16 Jun 2026 08:00:00 -0400 A.50216902 ADIL O.37097991 O.45953338 http://www.streetinsider.com/Press+Releases/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html <p align="justify">GLEN ALLEN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company’s newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company common stock as an inducement to them becoming employees of the Company in connection with the closing of its business combination with Azora Therapeutics, Inc. (“Azora”), which was previously announced by the Company on June 11, 2026. Additionally, the http://www.streetinsider.com/Press+Releases/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html Tue, 16 Jun 2026 08:00:00 -0400 A.50216902 ADIL O.37097991 O.45953338 http://www.streetinsider.com/Globe+Newswire/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html <p align="justify">GLEN ALLEN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company’s newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company common stock as an inducement to them becoming employees of the Company in connection with the closing of its business combination with Azora Therapeutics, Inc. (“Azora”), which was previously announced by the Company on June 11, 2026. Additionally, the http://www.streetinsider.com/Globe+Newswire/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html Tue, 16 Jun 2026 08:00:00 -0400 A.50216902 ADIL O.37097991 O.45953338 http://www.streetinsider.com/Globe+Newswire/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html <p align="justify">GLEN ALLEN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company’s newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company common stock as an inducement to them becoming employees of the Company in connection with the closing of its business combination with Azora Therapeutics, Inc. (“Azora”), which was previously announced by the Company on June 11, 2026. Additionally, the http://www.streetinsider.com/Globe+Newswire/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html Tue, 16 Jun 2026 08:00:00 -0400 A.50216902 ADIL O.37097991 O.45953338 http://www.streetinsider.com/Globe+Newswire/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html <p align="justify">GLEN ALLEN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company’s newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company common stock as an inducement to them becoming employees of the Company in connection with the closing of its business combination with Azora Therapeutics, Inc. (“Azora”), which was previously announced by the Company on June 11, 2026. Additionally, the http://www.streetinsider.com/Globe+Newswire/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html Tue, 16 Jun 2026 08:00:00 -0400 A.50216902 ADIL O.37097991 O.45953338 http://www.streetinsider.com/Globe+Newswire/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html <p align="justify">GLEN ALLEN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company’s newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company common stock as an inducement to them becoming employees of the Company in connection with the closing of its business combination with Azora Therapeutics, Inc. (“Azora”), which was previously announced by the Company on June 11, 2026. Additionally, the http://www.streetinsider.com/Globe+Newswire/Adial+Pharmaceuticals+Expands+Executive+Leadership+Team+and+Closes+PIPE+Financing/26650735.html Tue, 16 Jun 2026 08:00:00 -0400 A.50216902 ADIL O.37097991 O.45953338 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+11++Filed+by%3A+Davidson+Matt/26650085.html si-local-file:///var/storage/secattach/20260616/26650085.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+11++Filed+by%3A+Davidson+Matt/26650085.html Tue, 16 Jun 2026 06:37:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+11++Filed+by%3A+Davidson+Matt/26650085.html si-local-file:///var/storage/secattach/20260616/26650085.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+11++Filed+by%3A+Davidson+Matt/26650085.html Tue, 16 Jun 2026 06:37:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+11++Filed+by%3A+Davidson+Matt/26650076.html si-local-file:///var/storage/secattach/20260616/26650076.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+11++Filed+by%3A+Davidson+Matt/26650076.html Tue, 16 Jun 2026 06:35:00 -0400 ADIL O.37097991 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+11++Filed+by%3A+Davidson+Matt/26650076.html si-local-file:///var/storage/secattach/20260616/26650076.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++ADIAL+PHARMACEUTICALS%2C++++For%3A+Jun+11++Filed+by%3A+Davidson+Matt/26650076.html Tue, 16 Jun 2026 06:35:00 -0400 ADIL O.37097991